J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 38 (1978), 111-120; DOI 10.1099/0022-1317-38-1-111
© 1978 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sairenji, T.
Right arrow Articles by Yoshida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sairenji, T.
Right arrow Articles by Yoshida, M.
Agricola
Right arrow Articles by Sairenji, T.
Right arrow Articles by Yoshida, M.

Appearance of Early and Late Components of Epstein-Barr Virus-Associated Membrane Antigen in Daudi Cells Superinfected with P3HR-1 Virus

T. Sairenji*, Y. Hinuma*, T. Sekizawa{dagger} and M. Yoshida{ddagger}

* Department of Microbiology, Kumamoto University Medical School, Kumamoto, 860
{dagger} Department of Microbiology, Tohoku University School of Dentistry, Sendai, 980
{ddagger} Department of Pediatrics, Wakayama Medical College, Wakayama, 640 Japan

This study investigated the synthesis of membrane antigen (MA) as well as virus capsid antigen (VCA) and early antigen (EA) in Daudi cells which had been superinfected with the P3HR-1 strain of Epstein-Barr virus (EBV) and then treated with trypsin to remove initially absorbed MA-positive material from the cell surface. Synthesis of MA, VCA and EA was completely inhibited by puromycin. A marked reduction in the frequency of MA positive cells was observed in superinfected cells cultured in the presence of either cytosine arabinoside (Ara-C) or phosphonoacetate (PA); however, a small fraction of MA synthesis occurred, suggesting an inhibitor insensitive component in MA. A differential absorption of EBV antibody-positive human serum with the Ara-C treated or untreated infected cells detected two antigenically different components in MA: early (Ara-C insensitive) and late (Ara-C sensitive) MA.

Received 4 May 1977; accepted 29 July 1977.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1978 by the Society for General Microbiology.